Overview of What You Will Learn
On August 23, 2024, Johnson & Johnson sent a notice to 340B covered entities announcing a new method for providing 340B discounts on two of their products, STELARA and XARELTO. This new model requires 340B DSH hospitals to upload claims data to a third-party platform and collect the 340B discount as a rebate instead of accessing 340B prices at the point of sale.
This proposed model carries significant financial and operational implications for affected covered entities and is likely to face legal challenges. Our expert-led webinar will address the many questions arising from the 340B community regarding this significant change.
Meet Our Expert Speakers
- Nick Gnadt, PharmD, 340B ACE, Director of Pharmacy Professional Services, SpendMend
- Greg Wilson, PharmD, 340B ACE, Director of Compliance, SpendMend
Learning Objectives:
- Review the recent J&J policy notice for accessing 340B discounts for STELARA and XARELTO.
- Describe the financial, operational, regulatory, and judicial implications of this practice.
- Identify strategies and actions that covered entities may want to consider in response to this new practice.
Watch the Webinar
About the Speakers
Greg Wilson
PharmD, BCPS, 340B ACE
Greg Wilson, PharmD, BCPS, 340B ACE, is a Director of Compliance for SpendMend. In this role, he oversees independent external audits and provides covered entity support during the HRSA audit process. He has more than 15 years of health care experience serving in a variety of roles in hospital and health system pharmacy. Prior to joining SpendMend, he was the director of corporate pharmacy services for a large integrated delivery network based in Pittsburgh, PA, with responsibility for formulary management, medication-use policy, coordination of system-level P&T Committee activities, and oversight of 340B Program compliance and optimization.
.png)
Nick Gnadt
PharmD, 340B ACE
Nick Gnadt, PharmD, 340B ACE is a Director of Pharmacy Professional Services at SpendMend. In this role, he oversees a team of experienced 340B Specialists who support clients’ day-to-day 340B operations for short- or long-term staffing solutions. He has more than 15 years of experience in health care and most recently served as the Ambulatory Pharmacy Director at a large integrated delivery network in the upper Midwest. In that role he oversaw the health system’s 10+ 340B programs, MTM program, and retail pharmacies. Nick also served on the 340B Health Board of Directors for 5 years.